Galapagos NV
GLPG
#4947
Rank
HK$14.64 B
Marketcap
HK$218.00
Share price
-0.11%
Change (1 day)
4.42%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: HK$14.64 Billion

As of April 2026 Galapagos NV has a market cap of HK$14.64 Billion. This makes Galapagos NV the world's 4947th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$14.64 B-13.55%
2025HK$16.93 B21.26%
2024HK$13.96 B-33.24%
2023HK$20.92 B-8.36%
2022HK$22.82 B-19.86%
2021HK$28.48 B-43.25%
2020HK$50.19 B-52.29%
2019HK$105.21 B167.69%
2018HK$39.30 B4.75%
2017HK$37.52 B62.38%
2016HK$23.10 B20.95%
2015HK$19.10 B331.6%
2014HK$4.42 B-8.92%
2013HK$4.86 B10.95%
2012HK$4.38 B58.12%
2011HK$2.77 B-16.32%
2010HK$3.31 B67.51%
2009HK$1.97 B148.88%
2008HK$0.79 B

End of Day market cap according to different sources

On Apr 29th, 2026 the market cap of Galapagos NV was reported to be:

HK$14.38 Billion
by Nasdaq info icon info icon
HK$14.65 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.334 T 29,503.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.235 T 8,340.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$2.927 T 19,898.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$874.19 B 5,870.90%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$2.112 T 14,327.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$2.275 T 15,441.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$817.87 B 5,486.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
HK$0.59 B-95.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$319.87 B 2,084.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel